A listing of marjan-mujib medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
This study will compare treating participants with standard care, combined with early treatment with a cholesterol lowering drug called evolocumab (Repatha®) to treating participants with standard care alone. The study will measure reductions in heart attacks and strokes, procedures to improve blood flow, and death, compared to regular healthcare alone.